Document Detail

Oxytocin challenge test and intrauterine growth retardation.
MedLine Citation:
PMID:  7246629     Owner:  NLM     Status:  MEDLINE    
On the basis of analyses of the nonstressed fetal heart rate test (NST) and the oxytocin challenge test (OCT) in 85 fetuses with intrauterine growth retardation (IUGR), the predictive power of NST/OCT on fetal outcome and the mechanism of a positive OCT in IUGR were investigated. These fetuses with IUGR exhibited high incidences of nonreactive NSTs (35.3%) and positive OCTs (40%) attributable to a combination of compromised placental function and diminished fetal reserve. Adverse fetal prognosis is most accurately predicted by the joint occurrence of a nonreactive NST and a positive OCT (92%). In such cases, when IUGR is strongly suspected, liberal use of cesarean section is recommended to assure good fetal outcome.
C C Lin; L D Devoe; P River; A H Moawad
Related Documents :
15617699 - L-arginine treatment for asymmetric fetal growth restriction.
3892389 - Intrauterine growth in twin pregnancies: prediction of fetal growth retardation.
3675449 - Antepartum cardiotocography--an audit.
3303939 - In utero ponderal index as a prognostic factor in the evaluation of intrauterine growth...
11914689 - Intrauterine growth restriction.
12974059 - Ultrasound derived fetal growth curves for a jamaican population.
22137849 - Perceptions of teen motherhood in australian adolescent females: life-line or lifederai...
20602129 - The influence of folic acid supplementation on maternal and fetal bone turnover.
6538749 - Two successful pregnancies in a woman with chronic thrombotic thrombocytopenic purpura ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  140     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1981 Jun 
Date Detail:
Created Date:  1981-08-10     Completed Date:  1981-08-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  282-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cesarean Section
Estriol / analysis
Fetal Growth Retardation / diagnosis*,  therapy
Fetal Heart / drug effects
Infant Mortality
Oxytocin / diagnostic use*,  pharmacology
Pregnancy Complications / physiopathology
Reg. No./Substance:
50-27-1/Estriol; 50-56-6/Oxytocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Amniotic fluid phosphatidylglycerol: a potentially useful predictor of intrauterine growth retardati...
Next Document:  Fetal biophysical profile scoring: a prospective study in 1,184 high-risk patients.